GSK Investigational Site

Remscheid, North Rhine-Westphalia 42853

0 studies enrolling now · 1 studies all time

What they study most

Alzheimer's Disease

Studies at this site

• Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease — Completed